Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.036170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Lu Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing China. Hauptthemen laut MEDLINE: Heart Failure, Pyruvate Kinase, Ventricular Function, Left. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background The purpose of this study was to investigate whether circulating pyruvate kinase M2 (PK‐M2) levels are elevated in the peripheral blood and to assess their association with diagnosis and prognosis in patients with heart failure (HF). Methods and Results We conducted a prospective investigation involving 222 patients with HF and 103 control subjects, measuring PK‐M2 concentrations using ELISA. The primary outcome, assessed over a median follow‐up of 2 years (interquartile range: 776 to 926 days), was the time to the first occurrence of either rehospitalization for worsening HF or cardiovascular death. Patients with HF had higher PK‐M2 levels than controls (17.4±4.1 versus 7.8±2.3 U/mL, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing China.
- Department of Cardiology Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine Shanghai China.
- Department of Cardiology The Friendship Hospital of Ili Kazak Autonomous Prefecture Yining China.
- Department of Clincal Research Center Jiangnan University Medical Center Wuxi Jiangsu Province China.
- Department of Cardiology Liyang People's Hospital Liyang China.
ORCID-Profile: Xiaoyu Dong, Fuzhong Chen, Zhijun Han, Junhong Wang
Zitieren
APA
Cao, L., Dong, X., Chen, F., Li, G., Fang, J., Han, Z., & Wang, J. (2025). Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036170
Vancouver
Cao L, Dong X, Chen F, Li G, Fang J, Han Z, et al. Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036170
BibTeX
@article{Cao2025,
author = {Cao, Lu and Dong, Xiaoyu and Chen, Fuzhong and Li, Guangjuan and Fang, Jiale and Han, Zhijun and Wang, Junhong},
title = {Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.036170}
}
EUVIMED